84
74
Growth Score
-3 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
471652
This company is developing a new class of oligonucleotide therapeutics based on its proprietary platform technology.
Edvin N. Munk: CEO & President- Michelle Zaniboni: Vice President Finance
About the Company
We are an US-German biotechnology company located in San Diego and Bochum developing novel oligonucleotide therapeutics based on our platform technology for systemic delivery. Our compounds are highly active in virtually all organs, including tumors and metastases, therefore we focus on oncology.
